Benitrobenrazide

Overview

Benitrobenrazide (BNBZ) is the orally active inhibitor for hexokinase 2 with an IC 50 of 0.53 µM. Benitrobenrazide causes DNA damage, and exhibits antitumor effect.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Hexokinase | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-134929
• CAS No.: 2454676-05-0
• Molecular Formula: C14H11N3O6
• Molecular Weight: 317.25
• Purity: 99.50%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source